Natera Wins Cancer Test Injunction After $19M IP Verdict
A Delaware federal judge has barred Invitae Corp. from using its Personalized Cancer Monitoring test in certain ways that infringe patents owned by Natera Inc., according to a rare injunction made...To view the full article, register now.
Already a subscriber? Click here to view full article